Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)
CUSIP: 05337M104
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
- Shares outstanding
- 98,762,388
- Total 13F shares
- 7,025,014
- Share change
- -60,693,049
- Total reported value
- $98,771,327
- Price per share
- $14.06
- Number of holders
- 10
- Value change
- -$1,024,949,936
- Number of buys
- 3
- Number of sells
- 110
Quarterly Holders Quick Answers
What is CUSIP 05337M104?
CUSIP 05337M104 identifies AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05337M104:
Top shareholders of AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
13%
|
12,915,160
|
$218,181,602 | — | 31 Mar 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
8.9%
|
8,798,558
|
$148,607,645 | — | 31 Mar 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
6.8%
|
6,753,672
|
$114,069,520 | — | 31 Mar 2024 | |
| Jeffrey L. Gendell |
13F
|
Individual |
5.8%
|
5,708,118
|
$96,410,113 | — | 31 Mar 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
4%
|
3,972,099
|
$67,088,752 | — | 31 Mar 2024 | |
| BRAIDWELL LP |
13F
|
Company |
2.7%
|
2,668,549
|
$45,071,793 | — | 31 Mar 2024 | |
| WEALTH EFFECTS LLC |
13F
|
Company |
2.3%
|
2,264,226
|
$38,242,770 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.9%
|
1,910,983
|
$32,276,503 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.8%
|
1,812,317
|
$30,610,034 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.6%
|
1,563,890
|
$26,414,102 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.5%
|
1,500,524
|
$25,343,850 | — | 31 Mar 2024 | |
| BRANDES INVESTMENT PARTNERS, LP |
13F
|
Company |
1.5%
|
1,462,225
|
$24,696,981 | — | 31 Mar 2024 | |
| Tri Locum Partners LP |
13F
|
Company |
1.2%
|
1,189,511
|
$20,090,841 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,047,275
|
$17,688,475 | — | 31 Mar 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.98%
|
967,527
|
$16,341,531 | — | 31 Mar 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.88%
|
871,149
|
$14,713,707 | — | 31 Mar 2024 | |
| Checkpoint Capital L.P. |
13F
|
Company |
0.71%
|
701,387
|
$11,846,426 | — | 31 Mar 2024 | |
| Penn Capital Management Company, LLC |
13F
|
Company |
0.7%
|
686,606
|
$11,637,669 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.67%
|
665,411
|
$11,238,805 | — | 31 Mar 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.66%
|
653,147
|
$11,031,653 | — | 31 Mar 2024 | |
| Modera Wealth Management, LLC |
13F
|
Company |
0.61%
|
600,449
|
$10,141,584 | — | 31 Mar 2024 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.61%
|
600,000
|
$10,134,000 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.57%
|
565,000
|
$9,542,850 | — | 31 Mar 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.56%
|
553,057
|
$9,341,133 | — | 31 Mar 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.55%
|
547,036
|
$9,239,438 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.41%
|
406,006
|
$6,857,000 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.4%
|
399,551
|
$6,748,416 | — | 31 Mar 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.39%
|
387,770
|
$6,549,435 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.38%
|
374,203
|
$6,320,289 | — | 31 Mar 2024 | |
| David M. Knott Jr. |
13F
|
Individual |
0.34%
|
333,000
|
$5,624,000 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.33%
|
322,000
|
$5,438,580 | — | 31 Mar 2024 | |
| Two Seas Capital LP |
13F
|
Company |
0.32%
|
318,240
|
$5,375,074 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.31%
|
309,712
|
$5,231,036 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.29%
|
291,274
|
$4,919,618 | — | 31 Mar 2024 | |
| Obermeyer Wealth Partners |
13F
|
Company |
0.28%
|
279,494
|
$4,720,654 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.25%
|
249,160
|
$4,208,312 | — | 31 Mar 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.2%
|
193,233
|
$3,264,000 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.17%
|
168,528
|
$2,846,438 | — | 31 Mar 2024 | |
| SCHULHOFF & CO INC |
13F
|
Company |
0.14%
|
137,000
|
$2,313,930 | — | 31 Mar 2024 | |
| Dorsey Wright & Associates |
13F
|
Company |
0.13%
|
127,640
|
$2,155,511 | — | 31 Mar 2024 | |
| Jump Financial, LLC |
13F
|
Company |
0.13%
|
126,000
|
$2,128,140 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.12%
|
122,565
|
$2,070,000 | — | 31 Mar 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.12%
|
115,041
|
$1,943,044 | — | 31 Mar 2024 | |
| Cetera Investment Advisers |
13F
|
Company |
0.12%
|
113,978
|
$1,925,088 | — | 31 Mar 2024 | |
| MAI Capital Management |
13F
|
Company |
0.11%
|
111,605
|
$1,885,008 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
104,227
|
$1,760,394 | — | 31 Mar 2024 | |
| MML INVESTORS SERVICES, LLC |
13F
|
Company |
0.1%
|
101,931
|
$1,722,000 | — | 31 Mar 2024 | |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV |
13F
|
Company |
0.09%
|
87,375
|
$1,475,764 | — | 31 Mar 2024 | |
| Lion Point Capital, LP |
13F
|
Company |
0.08%
|
82,500
|
$1,393,425 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.08%
|
82,109
|
$1,386,821 | — | 31 Mar 2024 |
Institutional Holders of Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) as of Q2 2024
As of 30 Jun 2024,
Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,025,014 shares.
The largest 10 holders included
Vivo Capital, LLC, Tri Locum Partners LP, MPM BIOIMPACT LLC, Knoll Capital Management, LLC, Knott David M Jr, SCHULHOFF & CO INC, Ameritas Investment Partners, Inc., 1620 INVESTMENT ADVISORS, INC., CWM, LLC, and HUNTINGTON NATIONAL BANK.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
118
Q2 2024 holders
10
Holder diff
-108
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.